The Tübingen Centre for Academic Drug Discovery (TüCAD₂), founded in 2012, is part of the University's excellence strategy. TüCAD₂ is closely connected to the Excellence Cluster iFIT, ICEPHA (Interfaculty Center for Pharmacogenomics) and to NCT-SW (Nationales Zentrum für Tumorerkrankungen-SüdWest) and focus on pharmacological validation of genetically identified targets. The strong translational focus has brought four compounds "first into human" so far. An essential part of TüCAD₂ is a teaching concept, in which both a med chem curriculum and a MedChemCampus play a major part. Together with the GDCh Division of Medicinal Chemistry, TüCAD₂ started the MedChemCampus events in 2023, dealing with case studies, presented by eminent drug discovery experts from both industry and academia.

Topics: Case studies dealing with challenges in drug discovery
e.g. pharmacokinetics, structural biology, lead optimisation, safety, selectivity, brain-penetrance, resistance, macrocycles

Target Audience
- Young professionals in drug discovery & medicinal chemistry (academia and industry)
- PostDocs and graduate students in medicinal chemistry

15/16 September 2025
Tübingen
Website

10/11 October 2023
Tübingen
Flyer